Global footprint Merck Group operates across Life Science, Healthcare, and Electronics with a sizable multinational staff and a presence in 65 countries, presenting cross-business cross-sell opportunities to leverage its diversified portfolio and regional needs.

Innovation & AI With early adoption of generative AI via the MyGPT platform and a focus on science-driven innovation, there is a clear opening to offer data analytics, AI-enabled research tools, and cloud-based collaboration solutions tailored to R&D workflows.

Facility expansion Recent investments in new testing facilities and expanded campuses signal ongoing capacity growth and validation needs, suggesting opportunities in quality assurance, lab automation, instrumentation, and facility management technologies.

Strategic partnerships Engagements like the LangDock collaboration and NMIMS catalyst program indicate a preference for ecosystem partnerships, creating avenues for co-development agreements, training platforms, and jointly funded pilot projects.

Leadership & data New leadership in data governance and the company’s emphasis on data-driven decision making point to opportunities in data management platforms, enterprise analytics, cybersecurity, and compliance solutions for global operations.